Osmium(VI) complexes as a new class of potential anti-cancer agents.

@article{Ni2011OsmiumVICA,
  title={Osmium(VI) complexes as a new class of potential anti-cancer agents.},
  author={Wen-Xiu Ni and Wai-Lun Man and Myra Ting-Wai Cheung and Raymond Wai‐Yin Sun and Yuan-Lan Shu and Yun Wah Lam and Chi‐Ming Che and Tai-Chu Lau},
  journal={Chemical communications},
  year={2011},
  volume={47 7},
  pages={
          2140-2
        }
}
A nitridoosmium(VI) complex [Os(VI)(N)(sap)(OH(2))Cl] (H(2)sap = N-salicylidene-2-aminophenol) displays prominent in vitro and in vivo anti-cancer properties, induces S- and G2/M-phase arrest and forms a stable adduct with dianionic 5'-guanosine monophosphate. 

Topics from this paper

Osmium(VI) nitrido complexes bearing azole heterocycles: a new class of antitumor agents
Eight new nitridoosmium(VI) complexes with the general formula [OsVI(N)Cl3(Hazole)2] have been synthesized and characterized. The cellular uptake and the antiproliferative activities of theseExpand
Synthesis and antitumor activity of a series of osmium(VI) nitrido complexes bearing quinolinolato ligands.
A series of osmium(VI) nitrido complexes supported by quinolinolato ligands have been prepared and they exhibit promising in vitro anti-cancer activities. These results establish that Os(VI)≡N is aExpand
A cytotoxic tantalum(v) half-sandwich complex: a new challenge for metal-based anticancer agents.
TLDR
Potential chemotherapeutic applicability of the [Ta(η5-Cp*)Cl2(salaph)] (1) complex, containing deprotonated Schiff base 2-{(E)-[(2-hydroxyphenyl)imino]methyl}phenol (H2salaph) is demonstrated. Expand
A cytotoxic nitrido-osmium(VI) complex induces caspase-mediated apoptosis in HepG2 cancer cells.
TLDR
In vivo studies using HepG2-bearing nude mice reveal that the osmium(vi) nitrido complex shows good antitumor efficacy of inhibiting tumor growth, but also does not show the side effect of weight loss. Expand
Substituent-regulated highly X-ray sensitive Os(VI) nitrido complex for low-toxicity radiotherapy
Abstract A high efficiency and low toxicity radiosensitizer, OsN(PhenOH)Cl3, was designed and synthesized through substituent regulation. To the best of our knowledge, this is the first osmium-basedExpand
A potent antitumor Zn2+ tetraazamacrocycle complex targeting DNA: the fluorescent recognition, interaction and apoptosis studies.
TLDR
A Zn(2+) tetraazamacrocycle complex (2) bearing three naphthalene moieties has been prepared and shows considerable cytotoxicity against human cervical, breast and lung cancer cell lines with a different apoptotic pathway from that of cisplatin. Expand
Preparation of platinum(II) complexes with naphthalene imide derivatives and exploration of their in vitro cytotoxic activities
Abstract Two new platinum(II) complexes with naphthalene imide derivatives as the ligands, [Pt(3a)Cl]Cl (3a-Pt) and [Pt(3b)Cl]Cl (3b-Pt), where 3a =Expand
Bidentate ligands on osmium(VI) nitrido complexes control intracellular targeting and cell death pathways.
TLDR
To the best of the knowledge, 4 is the first osmium compound to induce ER stress in cancer cells. Expand
Complexes of platinum(II/IV) with 2-phenylpyridine derivatives as a new class of promising anti-cancer agents
Abstract Four platinum(II/IV) complexes, [PtIV(PPy)2Cl2]·CH3OH (Pt1), [PtIV(TFPy)2Cl2] (Pt2), [PtII(MPy)(H-MPy)Cl] (Pt3), and [PtII(DPPy)(H-DPPy)Cl] (Pt4) with 2-phenylpyridine (H-PPy),Expand
Anticancer Organometallic Osmium(II)‐p‐cymene Complexes
TLDR
Three bifunctional organometallic osmium(II)‐p‐cymene complexes functionalized with alkyl or perfluoroalkyl groups display selectivity toward cancer cells, with moderate cytotoxicity observed against human ovarian carcinoma cells, whereas no cytot toxicity was observed on non‐cancerous human embryonic kidney cells and human endothelial cells. Expand
...
1
2
3
4
...

References

SHOWING 1-10 OF 33 REFERENCES
Dual anti-angiogenic and cytotoxic properties of ruthenium(III) complexes containing pyrazolato and/or pyrazole ligands.
An oxo-bridged diruthenium(III) complex containing pyrazolato and pyrazole ligands is stable against ascorbic-acid reduction, induces apoptosis (60%, 48 h) against HeLa cells at 10 microM level andExpand
Tuning the reactivity of osmium(II) and ruthenium(II) arene complexes under physiological conditions.
TLDR
It is shown that the choice of chelating ligand in Os(II) (and Ru(II)) arene complexes can have a dramatic effect on hydrolysis behavior and nucleobase binding and provides a means of tuning the reactivity and the potential for discovery of anticancer complexes. Expand
Metal nitrido- and oxo-complexes. Part I. Complexes of ruthenium and osmium
The preparation and physical properties of the new complexes Cs2[Ru(N)X5] and R[M(N)X4](M = Ru or Os; R = Ph4As or Bun4N; X = Cl or Br) are described. New binuclear nitrido-bridged complexes ofExpand
DNA interactions of monofunctional organometallic osmium(II) antitumor complexes in cell-free media.
TLDR
This work is the first in-depth study of osmium binding to DNA and confirms the pharmacological activity of a new class of anticancer metallodrugs and indicates both a mechanism of action and a detoxification mechanism for OsII arene compounds different from those of cisplatin. Expand
Osmium(II)--versus ruthenium(II)--arene carbohydrate-based anticancer compounds: similarities and differences.
TLDR
Within this series of Os compounds, in vitro anticancer activity is highest for the most lipophilic chlorido complex dichlorido(eta(6)-p-cymene)(3,5,6-bicyclophosphite-1,2-O-cyclohexylidene-alpha-D-glucofuranoside)osmium(II). Expand
Ruthenium antimetastatic agents.
TLDR
This review article focuses on the development of new classes of ruthenium complexes originated from the NAMI-A frame, found to have antimetastatic activity comparable to, or even better than, Nami-A; however, the nature of the target(s) responsible for the antimetASTatic activity remains unclear. Expand
The anti-cancer properties of gold(III) compounds with dianionic porphyrin and tetradentate ligands
Abstract Gold(III) compounds have long been investigated for anti-cancer treatment. However, clinical use has often been hampered by their poor stability in solution. A reduction of gold(III) toExpand
Cytotoxicity, hydrophobicity, uptake, and distribution of osmium(II) anticancer complexes in ovarian cancer cells.
TLDR
There is a correlation between hydrophobicity (log P), cellular uptake, nucleus uptake, and cytotoxicity of the complexes, following the order 3 approximately 4 > 2 > 1, suggesting that the arene plays an important role in the biological activity of these types of compounds. Expand
The remarkable reactivity of high oxidation state ruthenium and osmium polypyridyl complexes.
There is a remarkable redox chemistry of higher oxidation state M(IV)-M(VI) polypyridyl complexes of Ru and Os. They are accessible by proton loss and formation of oxo or nitrido ligands, examplesExpand
[Os(IV)Cl(5)(Hazole)](-) complexes: synthesis, structure, spectroscopic properties, and antiproliferative activity.
TLDR
Compounds 6-11 were found to possess modest antiproliferative acitivity in vitro against CH1 (ovarian carcinoma), A549 (non-small cell lung carcinoma, and SW480 (colon adenocarcinoma) cells with IC(50) values in the 10(-4) M concentration range. Expand
...
1
2
3
4
...